Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 4
1990 4
1991 17
1992 24
1993 23
1994 36
1995 26
1996 48
1997 42
1998 39
1999 33
2000 39
2001 40
2002 37
2003 45
2004 39
2005 45
2006 50
2007 34
2008 37
2009 41
2010 40
2011 35
2012 35
2013 47
2014 53
2015 45
2016 49
2017 63
2018 53
2019 55
2020 66
2021 74
2022 55
Text availability
Article attribute
Article type
Publication date

Search Results

1,251 results
Results by year
Filters applied: . Clear all
Page 1
Epidermolysis bullosa: Advances in research and treatment.
Prodinger C, Reichelt J, Bauer JW, Laimer M. Prodinger C, et al. Exp Dermatol. 2019 Oct;28(10):1176-1189. doi: 10.1111/exd.13979. Epub 2019 Aug 8. Exp Dermatol. 2019. PMID: 31140655 Free PMC article. Review.
There is no cure for any of the subtypes of EB resulting from different mutations, and current therapy only focuses on the management of wounds and pain. Novel effective therapeutic approaches are therefore urgently required. Strategies include gene-, protein- and cell-bas …
There is no cure for any of the subtypes of EB resulting from different mutations, and current therapy only focuses on the management of wou …
Skin cancer precursor immunotherapy for squamous cell carcinoma prevention.
Rosenberg AR, Tabacchi M, Ngo KH, Wallendorf M, Rosman IS, Cornelius LA, Demehri S. Rosenberg AR, et al. JCI Insight. 2019 Mar 21;4(6):e125476. doi: 10.1172/jci.insight.125476. eCollection 2019 Mar 21. JCI Insight. 2019. PMID: 30895944 Free PMC article. Clinical Trial.
However, the long-term effectiveness of calcipotriol plus 5-FU treatment for SCC prevention is unknown. METHODS: We performed a blinded prospective cohort study on participants of a randomized double-blind clinical trial in which a 4-day course of topical calcipotriol …
However, the long-term effectiveness of calcipotriol plus 5-FU treatment for SCC prevention is unknown. METHODS: We performed a blind …
Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
McCormack PL. McCormack PL. Am J Clin Dermatol. 2011 Dec 1;12(6):421-4. doi: 10.2165/11207670-000000000-00000. Am J Clin Dermatol. 2011. PMID: 21967117 Review.
Calcipotriene (calcipotriol)/betamethasone dipropionate (calcipotriene 50 mug/g and betamethasone 0.5 mg/g) is a fixed-dose combination of a vitamin D3 analog and a corticosteroid indicated for the once-daily, topical treatment of psoriasis vulgaris of the tr …
Calcipotriene (calcipotriol)/betamethasone dipropionate (calcipotriene 50 mug/g and betamethasone 0.5 mg/g) is a fixed- …
Drugs for psoriasis.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2019 Jun 17;61(1574):89-96. Med Lett Drugs Ther. 2019. PMID: 31381544 Review. No abstract available.
[Calcipotriol].
Guilhou JJ. Guilhou JJ. Ann Dermatol Venereol. 2001 Mar;128(3 Pt 1):229-37. Ann Dermatol Venereol. 2001. PMID: 11319386 Free article. Review. French.
Calcipotriol is a vitamin D derivative synthesized in 1985 by the Leo Laboratories. ...Therapeutic trials in psoriasis have demonstrated the superiority of Calcipotriol over its excipient, class 2 dermatocorticoids, and reducers. ...
Calcipotriol is a vitamin D derivative synthesized in 1985 by the Leo Laboratories. ...Therapeutic trials in psoriasis have de …
Topical antipsoriatics.
Smith KC, Lebwohl M. Smith KC, et al. Skin Therapy Lett. 2000;5(2):1-2. Skin Therapy Lett. 2000. PMID: 10751842 Review.
However, there are other worthwhile options available including tar, anthralin, tazarotene, calcipotriol, topical PUVA, and topical porphyrin derivatives. With growing public reluctance to use systemic medications, topical treatments for psoriasis could become incre …
However, there are other worthwhile options available including tar, anthralin, tazarotene, calcipotriol, topical PUVA, and topical p …
Evaluating calcipotriene 0.005% foam for the treatment of plaque psoriasis of the scalp and body in patients aged 12 years and older.
Gao JC, Emmerich VK, Feldman S, Strowd LC. Gao JC, et al. Expert Opin Pharmacother. 2021 Apr;22(5):543-547. doi: 10.1080/14656566.2020.1853099. Epub 2020 Dec 1. Expert Opin Pharmacother. 2021. PMID: 33261508
Introduction: Topical corticosteroids are the mainstay of treatment for mild-to-moderate psoriasis in adult and adolescent patients but there can be many adverse events associated with long-term corticosteroid use. Corticosteroid-sparing alternatives include Vitamin D3 ana …
Introduction: Topical corticosteroids are the mainstay of treatment for mild-to-moderate psoriasis in adult and adolescent patients but ther …
Topical application of calcipotriene and corticosteroids: combination regimens.
Lebwohl M. Lebwohl M. J Am Acad Dermatol. 1997 Sep;37(3 Pt 2):S55-8. J Am Acad Dermatol. 1997. PMID: 9344186 Review.
BACKGROUND: Side effects of topical corticosteroids limit their long-term use. Calcipotriene/calcipotriol (Dovonex/Daivonex) ointment is not associated with any of the side effects of corticosteroids and has been shown to thicken the skin in contrast to the c …
BACKGROUND: Side effects of topical corticosteroids limit their long-term use. Calcipotriene/calcipotriol (Dovonex/Daiv …
The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
Thiers BH. Thiers BH. J Am Acad Dermatol. 1997 Sep;37(3 Pt 2):S69-71. J Am Acad Dermatol. 1997. PMID: 9344189 Review.
BACKGROUND: Topical calcipotriene ointment has been approved for the treatment of plaque-type psoriasis. OBJECTIVE: This article explores the possible use of topical calcipotriene ointment in the treatment of nail and intertriginous psoriasis, palmoplantar an …
BACKGROUND: Topical calcipotriene ointment has been approved for the treatment of plaque-type psoriasis. OBJECTIVE: This article expl …
Calcipotriol and psoriasis.
Ramsay CA. Ramsay CA. Int J Dermatol. 1992 Aug;31(8):549-50. doi: 10.1111/j.1365-4362.1992.tb02715.x. Int J Dermatol. 1992. PMID: 1428443 Review. No abstract available.
1,251 results